M&A Narrative Stress-Test
For Deal Teams, Corporate Development, and Integration Leaders
One of EYQA®'s 21 role-specific Narrative Stress-Tests — one standard of rigor, calibrated to your context.
In 5 minutes, this tool shows you where your M&A narrative would fracture under antitrust review, activist opposition, or shareholder litigation — before the deal timeline exposes it.
Where this applies
A sample of the 9 narrative types this assessment covers:
+ 4 more, including a custom option — choose yours when you start →
Free access · No credit card required · Takes 5 minutes
Already using EYQA tools? Sign in with your existing account.
EYQA® Narrative Defensibility Platform
M&A Narrative Stress-Test
For Deal Teams, Corporate Development, and Integration Leaders
Evaluate whether M&A narratives can withstand antitrust challenge and shareholder-litigation scrutiny.
Select Your M&A Narrative Type
Choose the narrative type most exposed to antitrust review, activist opposition, and shareholder litigation risk.
Apply Hostile Interpretation Lens (Optional)
Test your narrative's defensibility through the eyes of parties who scrutinize M&A decisions:
Regulatory Review: How would regulators interpret this narrative? Could disclosures be seen as misleading or incomplete?
You selected: [M&A Narrative Type]
Think of one specific M&A narrative that your organisation currently uses with investors, regulators, employees, customers, or the board.
Examples may include:
- How you explain the deal rationale to investors or analysts
- How you present the synergy case to the board or deal committee
- How you communicate the deal to employees on both sides
- How you respond to regulator or customer questions about the transaction
- How you describe integration milestones or cultural alignment
Answer all six questions based on that specific narrative as it exists today.
You do not need to upload the narrative to complete this assessment. By "narrative," we mean the specific way your organisation currently explains, presents, or communicates its M&A position. The narrative may be a formal presentation, a regulatory filing, an internal communication, a website or sales narrative, or another recurring explanation of the deal.
What this assessment evaluates
This assessment evaluates the defensibility of the narrative itself — whether its claims, evidence, logic, context, risk disclosure, and commitments are structured to withstand scrutiny from antitrust regulators, activist investors, proxy advisors, and litigation counsel.
This is a narrative readiness diagnostic. It is not legal advice, a fairness opinion, or a guarantee of regulatory approval or shareholder support.
This assessment evaluates how defensibly the narrative presents and supports its claims. It does not independently verify the underlying deal assumptions or financial projections.
The six dimensions assess the defensibility of the narrative itself:
These dimensions are designed to assess narrative defensibility across different M&A contexts. They do not replace detailed legal or financial advice.
Assess Your M&A Narrative Defensibility
Answer 6 questions about the specific M&A narrative you identified. Be honest about its current state — this is a diagnostic, not a legal review.
Testing through: [No hostile lens selected]
Synergy & Value Evidence
Are projected synergies and value creation backed by verifiable diligence data, or are they optimistic assumptions dressed up as fact?
Strategic Rationale Coherence
Does the rationale logically explain why this deal, this target, and this price — or does it lean on generic "growth" language that would fit any acquisition?
Multi-Stakeholder Perspective
Does the narrative address employees on both sides, customers, and investors differently, or is it a single script for everyone?
Integration & Regulatory Risk Disclosure
Are integration risks, cultural friction points, and antitrust or regulatory hurdles honestly disclosed, or glossed over to make the deal look smoother than it is?
Audience & Deal-Stage Calibration
Is the messaging calibrated to this exact deal stage — signing, regulatory review, or Day 1 — and this specific audience, or generic across the whole deal timeline?
Integration Milestone Commitment
Does the narrative commit to specific integration milestones and a timeline, or stay vague with "we'll figure it out together"?
Assessment for: [M&A Narrative Type]
From Defensibility Assessment to Governance Action
Your defensibility score measures exposure to regulatory hindsight and stakeholder reinterpretation. Here's how to translate it into governance action:
Based on your defensibility score above, choose your next step:
AI-Assisted Preview Prompt
A calibrated review prompt you run in your own LLM of choice. Not an analysis performed by EYQA — see disclosure before use.
Get Detailed Expert Analysis
Supplement this automated score with a comprehensive, human-led defensibility analysis from EYQA governance narrative specialists.
Submit your actual M&A narrative for human-led scrutiny exposure assessment.
All submissions are confidential and analyzed by EYQA experts only.
Ready for M&A defensibility consultation?
45-minute M&A defensibility review
Professional Use & Framework Intent
EYQA® M&A Narrative Stress-Tests are designed as professional reflection and scrutiny tools to support deal decision-making in high-stakes antitrust and litigation contexts.
This assessment is intended for personal or internal professional use to evaluate M&A narrative defensibility under regulatory and shareholder scrutiny. It does not constitute legal advice, governance certification, or regulatory compliance verification.
This assessment applies predefined professional governance evaluation frameworks. No AI-based scoring, deal recommendations, or decision-making is performed.
Insights generated are diagnostic in nature. Deal team members and corporate development leaders remain fully responsible for fiduciary duties, deal decisions, and how assessment results are interpreted and applied.
All frameworks, structures, assessment designs, and governance evaluation methodologies are the intellectual property of EYQA®. Use does not transfer ownership or licensing rights.
EYQA® reserves all rights to modify, restrict, or terminate free access to this M&A narrative stress-test tool at any time, with or without notice.